634 related articles for article (PubMed ID: 8143497)
21. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.
Ho TW; Mishu B; Li CY; Gao CY; Cornblath DR; Griffin JW; Asbury AK; Blaser MJ; McKhann GM
Brain; 1995 Jun; 118 ( Pt 3)():597-605. PubMed ID: 7600081
[TBL] [Abstract][Full Text] [Related]
22. Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni.
Ohtsuka K; Nakamura Y; Hashimoto M; Tagawa Y; Takahashi M; Saito K; Yuki N
Ophthalmology; 1998 Jul; 105(7):1281-5. PubMed ID: 9663234
[TBL] [Abstract][Full Text] [Related]
23. Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a patient with GVHD after allogeneic BMT.
Hagensee ME; Benyunes M; Miller JA; Spach DH
Bone Marrow Transplant; 1994 Mar; 13(3):349-51. PubMed ID: 8199580
[TBL] [Abstract][Full Text] [Related]
24. [Antibody response following Campylobacter infections determined by ELISA].
Engberg JH; Strid MA; Mølbak K; Krogfelt KA
Ugeskr Laeger; 2003 Jun; 165(24):2485-6. PubMed ID: 12872469
[TBL] [Abstract][Full Text] [Related]
25. [Campylobacter jejuni infection in patient with Guillain-Barré syndrome: a case report].
Kopyta I; Wardak S
Med Dosw Mikrobiol; 2008; 60(1):59-63. PubMed ID: 18634345
[TBL] [Abstract][Full Text] [Related]
26. Utility of serum Campylobacter specific antibodies in determining prior Campylobacter infection in neurological disease.
Taylor BV; Williamson J; Jones D; Coleman D; Luck J; McGregor A
J Clin Neurosci; 2007 Feb; 14(2):116-21. PubMed ID: 17107803
[TBL] [Abstract][Full Text] [Related]
27. [Guillain-barré syndrome associated Campylobacter jejuni serotype Penner 2: a case report].
Watanabe M; Kinoshita I; Hujimoto M; Nakane S; Motomura M; Nakamura T; Kusunoki S; Takahashi M; Saitoh K
No To Shinkei; 2001 Aug; 53(8):759-62. PubMed ID: 11577419
[TBL] [Abstract][Full Text] [Related]
28. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.
Schmidt-Ott R; Schmidt H; Feldmann S; Brass F; Krone B; Gross U
Clin Vaccine Immunol; 2006 Jul; 13(7):779-83. PubMed ID: 16829615
[TBL] [Abstract][Full Text] [Related]
29. [A patient with Guillain-Barré syndrome in association with Campylobacter jejuni enteritis (PEN19:LIO7) in a patient with HLA-B52 antigen].
Kaida K; Yuki N; Takahashi M; Kamakura K; Nagata N
Rinsho Shinkeigaku; 1994 Jul; 34(7):733-5. PubMed ID: 7955736
[TBL] [Abstract][Full Text] [Related]
30. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh.
Islam Z; Jacobs BC; van Belkum A; Mohammad QD; Islam MB; Herbrink P; Diorditsa S; Luby SP; Talukder KA; Endtz HP
Neurology; 2010 Feb; 74(7):581-7. PubMed ID: 20157160
[TBL] [Abstract][Full Text] [Related]
31. Campylobacter jejuni and Guillain-Barré syndrome.
Rees JH; Hughes RA
Ann Neurol; 1994 Feb; 35(2):248-9. PubMed ID: 8109911
[No Abstract] [Full Text] [Related]
32. [A case of Guillain-Barré syndrome after Campylobacter jejuni enterocolitis: anti-ganglioside antibody levels with or without Guillain-Barré syndrome].
Watanabe H; Shindo K; Nakamura Y; Nagamatsu M; Shiozawa Z; Kusunoki S
Rinsho Shinkeigaku; 2001 Sep; 41(9):625-7. PubMed ID: 11968750
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity and specificity of serology in determining recent acute Campylobacter infection.
Taylor BV; Williamson J; Luck J; Coleman D; Jones D; McGregor A
Intern Med J; 2004 May; 34(5):250-8. PubMed ID: 15151671
[TBL] [Abstract][Full Text] [Related]
34. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
35. Association of Campylobacter jejuni infection and GuillainBarré syndrome: a cohort study in the northwest of Iran.
Barzegar M; Alizadeh A; Toopchizadeh V; Dastgiri S; Majidi J
Turk J Pediatr; 2008; 50(5):443-8. PubMed ID: 19102048
[TBL] [Abstract][Full Text] [Related]
36. [Axonal Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni (PEN 43) enteritis].
Ihara Y; Saito K; Yoshimoto S; Hayabara T; Yuki N
Rinsho Shinkeigaku; 1995 Aug; 35(8):901-3. PubMed ID: 8665735
[TBL] [Abstract][Full Text] [Related]
37. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
Yuki N
Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
[TBL] [Abstract][Full Text] [Related]
38. Campylobacter jejuni infection and Guillain-Barre syndrome.
Aguago JM; Ramos JT; Lumbreras C
N Engl J Med; 1996 Mar; 334(12):802. PubMed ID: 8592566
[No Abstract] [Full Text] [Related]
39. [Guillain-Barré syndrome of axonal type, Campylobacter jejuni infection and anti-ganglioside GM1 antibodies].
Attarian S; Bonnefoi-Kyriacou B; Gayraud D; Mignard P; Boucraut J; Pouget J; Viallet F
Rev Neurol (Paris); 1997 Apr; 153(3):205-8. PubMed ID: 9296136
[TBL] [Abstract][Full Text] [Related]
40. Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects.
Tribble DR; Baqar S; Carmolli MP; Porter C; Pierce KK; Sadigh K; Guerry P; Larsson CJ; Rockabrand D; Ventone CH; Poly F; Lyon CE; Dakdouk S; Fingar A; Gilliland T; Daunais P; Jones E; Rymarchyk S; Huston C; Darsley M; Kirkpatrick BD
Clin Infect Dis; 2009 Nov; 49(10):1512-9. PubMed ID: 19842970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
